Literature DB >> 17147915

Hypertension and heart failure: diagnosis and management.

Kevin A Courville1, Hector Ventura.   

Abstract

Heart failure continues to be a significant problem faced by today's health care professional. Heart failure remains one of the principal causes of cardiovascular morbidity and mortality. The prevalence of heart failure continues to increase, largely due to an aging population and to modern technologic innovations that have led to prolonged survival of the cardiac patient. Hypertension increases the risk for heart failure in all age groups. In those individuals aged 40 years or older whose blood pressure is > 140/90 mm Hg, the lifetime risk for developing heart failure may be twice as high as that of their aged-matched counterparts. Therefore, it is imperative that the clinician be aware of the current diagnostic and therapeutic advancements for the early detection and aggressive treatment of hypertension and heart failure, to prevent patients from developing symptoms of heart failure and to decrease the need for hospitalizations once the diagnosis is confirmed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147915     DOI: 10.1007/s11906-006-0049-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  43 in total

1.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Arch Intern Med       Date:  1999-01-11

2.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance.

Authors:  J F Setaro; B L Zaret; D S Schulman; H R Black; R Soufer
Journal:  Am J Cardiol       Date:  1990-10-15       Impact factor: 2.778

3.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

4.  Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.

Authors:  J G Warner; D C Metzger; D W Kitzman; D J Wesley; W C Little
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

5.  Association of body mass, gender and race with heart failure primarily due to hypertension.

Authors:  S H Dunlap; C A Sueta; L Tomasko; K F Adams
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

6.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 8.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective.

Authors:  R S Vasan; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

9.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

10.  10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists.

Authors:  R Hopf; M Kaltenbach
Journal:  Z Kardiol       Date:  1987
View more
  1 in total

Review 1.  The association between overactive bladder and diuretic use in the elderly.

Authors:  O James Ekundayo
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.